Cardinal Health, Inc. (CAH) Expected to Announce Earnings of $1.03 Per Share
Equities analysts predict that Cardinal Health, Inc. (NYSE:CAH) will announce earnings per share of $1.03 for the current quarter, according to Zacks. Three analysts have issued estimates for Cardinal Health’s earnings, with the lowest EPS estimate coming in at $0.97 and the highest estimate coming in at $1.18. Cardinal Health reported earnings of $1.24 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 16.9%. The firm is expected to report its next earnings results on Monday, October 30th.
On average, analysts expect that Cardinal Health will report full-year earnings of $4.96 per share for the current fiscal year, with EPS estimates ranging from $4.90 to $5.00. For the next fiscal year, analysts expect that the firm will report earnings of $5.56 per share, with EPS estimates ranging from $5.40 to $5.65. Zacks’ EPS calculations are a mean average based on a survey of research firms that cover Cardinal Health.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.14 EPS.
Several equities analysts recently issued reports on the stock. UBS AG reiterated a “neutral” rating and set a $76.00 price target (down previously from $79.00) on shares of Cardinal Health in a research report on Thursday, August 3rd. Credit Suisse Group reiterated an “outperform” rating and set a $87.00 price target (up previously from $81.00) on shares of Cardinal Health in a research report on Thursday, July 13th. Barclays PLC reiterated an “overweight” rating and set a $82.00 price target (down previously from $88.00) on shares of Cardinal Health in a research report on Saturday, April 22nd. William Blair cut shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 19th. Finally, BidaskClub cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $80.46.
COPYRIGHT VIOLATION NOTICE: “Cardinal Health, Inc. (CAH) Expected to Announce Earnings of $1.03 Per Share” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/08/08/cardinal-health-inc-cah-expected-to-announce-earnings-of-1-03-per-share.html.
Cardinal Health (NYSE CAH) opened at 69.24 on Tuesday. The stock’s 50 day moving average is $77.38 and its 200-day moving average is $77.27. The company has a market cap of $21.88 billion, a PE ratio of 17.18 and a beta of 0.80. Cardinal Health has a 52-week low of $62.70 and a 52-week high of $84.90.
In other news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the company’s stock in a transaction that occurred on Friday, May 12th. The shares were sold at an average price of $72.87, for a total value of $1,695,684.90. Following the transaction, the insider now owns 55,440 shares in the company, valued at $4,039,912.80. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.94% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Tompkins Financial Corp increased its position in shares of Cardinal Health by 38.0% in the first quarter. Tompkins Financial Corp now owns 11,541 shares of the company’s stock valued at $946,000 after buying an additional 3,176 shares in the last quarter. Alpha Windward LLC increased its position in shares of Cardinal Health by 1.8% in the first quarter. Alpha Windward LLC now owns 2,282 shares of the company’s stock valued at $186,000 after buying an additional 41 shares in the last quarter. Private Trust Co. NA increased its position in shares of Cardinal Health by 0.3% in the first quarter. Private Trust Co. NA now owns 13,731 shares of the company’s stock valued at $1,119,000 after buying an additional 41 shares in the last quarter. Honkamp Krueger Financial Services Inc. increased its position in shares of Cardinal Health by 1.3% in the first quarter. Honkamp Krueger Financial Services Inc. now owns 4,575 shares of the company’s stock valued at $373,000 after buying an additional 60 shares in the last quarter. Finally, Regentatlantic Capital LLC increased its position in shares of Cardinal Health by 2.0% in the first quarter. Regentatlantic Capital LLC now owns 3,739 shares of the company’s stock valued at $305,000 after buying an additional 74 shares in the last quarter. Hedge funds and other institutional investors own 87.09% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.